Northpond Ventures GP II, LLC - Oct 15, 2024 Form 4 Insider Report for Camp4 Therapeutics Corp (CAMP)

Role
10%+ Owner
Signature
Northpond Ventures II GP, LLC, By: /s/ Patrick Smerkers, Authorized Signatory
Stock symbol
CAMP
Transactions as of
Oct 15, 2024
Transactions value $
$8,399,996
Form type
4
Date filed
10/17/2024, 06:34 PM
Previous filing
Oct 10, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CAMP Common Stock Conversion of derivative security +1M 1M Oct 15, 2024 By Northpond Ventures II, LP F1, F2
transaction CAMP Common Stock Conversion of derivative security +471K 471K Oct 15, 2024 By Northpond Ventures, LP F1, F3
transaction CAMP Common Stock Purchase $8.4M +764K $11.00 764K Oct 15, 2024 By Northpond Ventures III, LP F4

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CAMP Series A Prime Preferred Stock Conversion of derivative security -11.3M -100% 0 Oct 15, 2024 Common Stock 1M By Northpond Ventures II, LP F1, F2
transaction CAMP Series B Preferred Stock Conversion of derivative security -5.29M -100% 0 Oct 15, 2024 Common Stock 471K By Northpond Ventures, LP F1, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each share of Series A Prime Preferred Stock and Series B Preferred Stock (collectively, the "Preferred Stock") converted into shares of Common Stock of the Issuer on a 11.2158-for-one basis without payment of further consideration. Immediately prior to the closing of the Issuer's initial public offering, the Preferred Stock was converted into the number of shares of Common Stock of the Issuer shown in column 7 of Table II. The Preferred Stock had no expiration date.
F2 The shares are held directly by Northpond Ventures II, LP ("Northpond Fund II"). Northpond Ventures II GP, LLC ("Northpond II GP") is the general partner of Northpond Fund II, and Michael P. Rubin is the managing member of Northpond II GP. As a result, each of Northpond II GP and Mr. Rubin may be deemed to share beneficial ownership with respect to the shares held of record by Northpond Fund II. Each of Northpond II GP and Mr. Rubin disclaim beneficial ownership of the securities reported herein, except to the extent of such Reporting Person's pecuniary interest therein, if any.
F3 The shares are held directly by Northpond Ventures, LP ("Northpond Fund I"). Northpond Ventures GP, LLC ("Northpond GP I") is the general partner of Northpond Fund I, and Michael P. Rubin is the managing member of Northpond GP I. As a result, each of Northpond GP I and Mr. Rubin may be deemed to share beneficial ownership with respect to the shares held of record by Northpond Fund I. Each of Northpond GP I and Mr. Rubin disclaim beneficial ownership of the securities reported herein, except to the extent of such Reporting Person's pecuniary interest therein, if any.
F4 The shares are held directly by Northpond Ventures III, LP ("Northpond Fund III"). Northpond Ventures III GP, LLC ("Northpond III GP") is the general partner of Northpond Fund III, and Michael P. Rubin is the managing member of Northpond III GP. As a result, each of Northpond III GP and Mr. Rubin may be deemed to share beneficial ownership with respect to the shares held of record by Northpond Fund III. Each of Northpond III GP and Mr. Rubin disclaim beneficial ownership of the securities reported herein, except to the extent of such Reporting Person's pecuniary interest therein, if any.